Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions

v3.21.2
Significant Transactions
6 Months Ended
Jun. 30, 2021
Significant Transactions [Abstract]  
Significant Transactions

Note 4 – Significant Transactions

 

Viridian Sciences

 

On April 1, 2021, we completed the acquisition of Viridian Sciences Inc. (“Viridian”), a cannabis business management software provider that is built on SAP Business One. We acquired Viridian in exchange for $6.0 million of our common stock. In addition to the stock consideration, the agreement provides for contingent consideration of up to $1.0 million, payable in additional common stock, if Viridian meets certain revenue criteria. The contingent consideration will be recorded as the estimated fair value on the acquisition date and adjusted to estimated fair value in each subsequent reporting period until settlement.

 

 

 

Preliminary
Fair Value

 

Shares issued

 

$

6,000

 

Contingent consideration

2
Total preliminary fair value of consideration transferred
$ 6,002

 

The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): 

 

 

 

Preliminary
Fair Value

 

Accounts receivable

 

 

556

 

Prepaid expenses and other current assets

 

 

71

 

Capitalized software

500

Acquired technology

 

 

470

 

Customer relationships

820
Acquired trade name

20
Goodwill

4,915

Accounts payable and accrued expenses

 

 

(350

)

Deferred revenue

 

 

(1,000

)

Net assets acquired

 

$

6,002

 

 

The excess of purchase consideration over the fair value of assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities, for which there is no basis for U.S. income tax purposes. The fair values assigned to identifiable assets acquired and liabilities assumed are based on management’s estimates and assumptions.    

 

Pro Forma Financial Information


The following unaudited pro forma financial information for the six months ended June 30, 2021 and the three and six months ended June 30, 2020 summarizes the combined results of operations for Akerna, Trellis, Solo, Ample and Viridian as though the companies were combined as of January 1, 2019 (in thousands):



 Six Months Ended
June 30,




2021
Revenue $ 9,929
Net loss $ (12,561 )


 Three Months Ended
June 30,




2020
Revenue $ 5,506
Net loss $ (7,072 )



Six Months Ended
 June 30,



2020
Revenue $ 11,362
Net loss $ (13,431 )


The pro forma financial information for all periods presented above has been calculated after adjusting the results of Trellis, Ample and Viridian to reflect the business combination accounting effects resulting from these acquisitions, including the amortization expense from acquired intangible assets as though the acquisition occurred as of the beginning of the Company’s fiscal year 2019. The Akerna historical condensed consolidated financial statements have been adjusted in the pro forma combined financial statements to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The pro forma financial information is for illustrative and informational purposes only and is not intended to represent or be indicative of what the results of operations would have been had the Ample acquisition taken place at the beginning of the Company’s fiscal year 2019.


Special Voting Preferred Stock and Exchangeable Shares


In connection with the Ample acquisition, we entered into agreements with our wholly-owned subsidiary and the Ample shareholder representative that resulted in the issuance of a single share of our special voting preferred stock, for the purpose of ensuring that each Exchangeable Share is substantially the economic and voting equivalent of a share of Akerna common stock, and, following the registration of the Akerna shares issuable upon exchange of the Exchangeable Shares under the Securities Act of 1933, ensuring that each Exchangeable Share is exchangeable on a one-for-one basis for a share of Akerna common stock, subject to certain limitations. As a result of these agreements and the issuance of the special voting preferred stock, each holder of Exchangeable Shares effectively has the ability to cast votes along with holders of Akerna common stock. Additionally, these agreements grant exchange rights to the holders of exchangeable shares upon the event of our liquidation, dissolution or winding up.


The special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00. The special voting preferred stock entitles the holder to an aggregate number of votes equal to the number of the exchangeable shares issued and outstanding from time to time and which we do not own. The holder of the special voting preferred stock and the holders of shares of Akerna common stock will both together as a single class on all matters submitted to a vote of our shareholders. At such time as the special voting preferred stock has no votes attached to it, the share shall be automatically cancelled. The exchangeable shares do not have a par value.


During the six months ended June 30, 2021, several Ample shareholders exchanged a total of 607,914 exchangeable shares with a value of $4,650,542 for the same number of shares of Akerna common stock. The exchange was accounted for as an equity transaction and we did not recognize a gain or loss on this transaction. As of June 30, 2021, there were a total of 1,039,373 exchangeable shares issued and outstanding.